logo
Introduction
Effects of Clozapine on Positive and Negative Symptoms in Outpatients With Schizophrenia
Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns
Positive and Negative Symptoms Covary During Clozapine Treatment in Schizophrenia
Clozapine-Induced Agranulocytosis: Incidence and Risk Factors in the United States
Clozapine Response in Treatment-Refractory First-Episode Schizophrenia
Relationship Between Clinical Efficacy and Clozapine Concentrations in Plasma in Schizophrenia: Effect of Smoking
Serotonin Function and Treatment Response to Clozapine in Schizophrenic Patients
Cost Effectiveness of Clozapine in Neuroleptic-Resistant Schizophrenia
Idazoxan, an alpha2 Antagonist, Augments Fluphenazine in Schizophrenic Patients: A Pilot Study
Risperidone Versus Perphenazine in the Treatment of Chronic Schizophrenic Patients With Acute Exacerbations
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses
Dose-Response Study of N,N-Dimethyltryptamine in Humans: II. Subjective Effects and Preliminary Results of a New Rating Scale
Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial
Subjective Response to Neuroleptics in Schizophrenia
Can Estradiol Modulate Schizophrenic Symptomatology?
Optimal Drug and Behavior Therapy for Treatment-Refractory Schizophrenic Patients
Relation of Plasma Fluphenazine Levels to Treatment Response and Extrapyramidal Side Effects in First-Episode Schizophrenia Patients
Fluphenazine vs Placebo Supplementation for Prodromal Signs of Relapse in Schizophrenia
Treatment of Late-Life Schizophrenia With Neuroleptics
Hypnotics as Concurrent Medication in Depression: A Placebo-Controlled, Double-Blind Comparison of Flunitrazepam and Lormetazepam in Patients With Major Depression, Treated With a (Tri)cyclic Antidepressant
Age and the Effects of ECT
A Randomized Double-Blind Study of Fluoxetine Versus Placebo in the Treatment of Dysthymia
Anger Attacks in Unipolar Depression, Part 1: Clinical Correlates and Response to Fluoxetine Treatment
Use of Minor Tranquilizers and Antidepressant Medications by Depressed Outpatients: Results From the Medical Outcomes Study
A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression
Outcome After Rapid vs Gradual Discontinuation of Lithium Treatment in Bipolar Disorders
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania
Electroconvulsive Therapy of Acute Manic Episodes: A Review of 50 Years' Experience
Treatment of Depression in Bipolar Disorder: New Directions for Research
Lithium-Induced Renal Insufficiency
Long-Term Outcome After Acute Treatment With Alprazolam or Clonazepam for Panic Disorder
The Relative Efficacy of High-Dose Buspirone and Alprazolam in the Treatment of Panic Disorder: A Double-Blind Placebo-Controlled Study
Effects of the Serotonin Reuptake Inhibitor Fluvoxamine on Yohimbine-Induced Anxiety in Panic Disorder
A Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Ipsapirone Versus Lorazepam in Patients With Generalized Anxiety Disorder: A Prospective Multicenter Trial
Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder: A Double-Blind, Placebo-Controlled Study in Patients With and Without Tics
Predictors of Short-Term Treatment Response in 66 Patients With Panic Disorder
Anxiety Psychopathology Predictive of Outcome in Patients With Panic Disorder and Depression Treated With Imipramine, Alprazolam and Placebo
Double-Blind, Placebo-Controlled Study of a Once-a-Day, Sustained-Release Preparation of Alprazolam for the Treatment of Panic Disorder
A Randomized Double-Blind Placebo-Controlled Study of Tropisetron in the Treatment of Outpatients With Generalized Anxiety Disorder
Antidepressants for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Comparison of Imipramine, Trazodone, and Diazepam
Fatal Poisonings Attributed to Benzodiazepines in Britain During the 1980s
Treatment of Social Phobia With Clonazepam and Placebo
Sedatives and Suicide: The San Diego Study
A Pilot Placebo-Controlled Study of Trazodone and Buspirone in Alzheimer's Disease
Memory Improvement Without Toxicity During Chronic, Low Dose Intravenous Arecoline in Alzheimer's Disease
Efficacy of Phenelzine and Haloperidol in Borderline Personality Disorder
Fluoxetine for Cocaine Dependence in Methadone Maintenance: Quantitative Plasma and Urine Cocaine/Benzoylecgonine Concentrations
Effect of a Long-Lasting Gonadotrophin Hormone-Releasing Hormone Agonist in Six Cases of Severe Male Paraphilia